Similar articles for PMID: 16235180

Year	Number of Results
1992	1
1995	1
1996	6
1998	2
1999	1
2000	8
2001	10
2002	9
2003	11
2004	11
2005	19
2006	14
2007	14
2008	15
2009	27
2010	15
2011	13
2012	9
2013	10
2014	10
2015	10
2016	8
2017	5
2018	1
2019	3
2020	4
2021	1
2022	1
2024	0

1

Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.

Miiro G, Kayhty H, Watera C, Tolmie H, Whitworth JA, Gilks CF, French N. Miiro G, et al. J Infect Dis. 2005 Nov 15;192(10):1801-5. doi: 10.1086/497144. Epub 2005 Oct 5. J Infect Dis. 2005. PMID: 16235180 Clinical Trial.

2

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.

Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T. Thanee C, et al. Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3. Vaccine. 2011. PMID: 21729732 Clinical Trial.

3

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.

Lesprit P, Pédrono G, Molina JM, Goujard C, Girard PM, Sarrazin N, Katlama C, Yéni P, Morineau P, Delfraissy JF, Chêne G, Lévy Y; ANRS 114-Pneumovac Study Group. Lesprit P, et al. AIDS. 2007 Nov 30;21(18):2425-34. doi: 10.1097/QAD.0b013e3282887e91. AIDS. 2007. PMID: 18025879 Clinical Trial.

4

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I; Pediatric AIDS Clinical Trials Group P1024 Protocol Team. Abzug MJ, et al. Pediatr Infect Dis J. 2006 Oct;25(10):920-9. doi: 10.1097/01.inf.0000237830.33228.c3. Pediatr Infect Dis J. 2006. PMID: 17006288

5

A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.

French N, Moore M, Haikala R, Kayhty H, Gilks CF. French N, et al. J Infect Dis. 2004 Aug 15;190(4):707-12. doi: 10.1086/421911. Epub 2004 Jul 16. J Infect Dis. 2004. PMID: 15272398

6

Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.

Onwubiko C, Swiatlo E, McDaniel LS. Onwubiko C, et al. J Clin Microbiol. 2008 Nov;46(11):3621-5. doi: 10.1128/JCM.01245-08. Epub 2008 Sep 24. J Clin Microbiol. 2008. PMID: 18845823 Free PMC article.

7

Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults.

Peñaranda M, Payeras A, Cambra A, Mila J, Riera M; Majorcan Pneumococcal Study Group. Peñaranda M, et al. AIDS. 2010 May 15;24(8):1226-8. doi: 10.1097/QAD.0b013e3283389de5. AIDS. 2010. PMID: 20299956 Clinical Trial.

8

IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H; ARIVAC Consortium. Soininen A, et al. Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19428879 Clinical Trial.

9

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L. Vesikari T, et al. Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S66-76. doi: 10.1097/INF.0b013e318199f8ef. Pediatr Infect Dis J. 2009. PMID: 19325449 Clinical Trial.

10

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L. Wysocki J, et al. Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S77-88. doi: 10.1097/INF.0b013e318199f609. Pediatr Infect Dis J. 2009. PMID: 19325450 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

214 results

Results by year